Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.

Neurology - 11 Feb 2014

Sato Douglas Kazutoshi, Callegaro Dagoberto, Lana-Peixoto Marco Aurelio, Waters Patrick J, de Haidar Jorge Frederico M, Takahashi Toshiyuki, Nakashima Ichiro, Apostolos-Pereira Samira Luisa, Talim Natalia, Simm Renata Faria, Lino Angelina Maria Martins, Misu Tatsuro, Leite Maria Isabel, Aoki Masashi, Fujihara Kazuo

Abstract excerpt

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aquaporin 4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoantibodies

Share to Child, Preschool

Share to Myelin-Oligodendrocyte Glycoprotein

Share to Neuromyelitis Optica

Share to Sex Factors

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 24415568
DOI: 10.1212/WNL.0000000000000101
PMCID: PMC3937859

Genes

AQP4
MOG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.PMID 24415568Read ↗

The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia.Semantic proximity Read ↗

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.Semantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.Semantic proximity Read ↗

Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes.Semantic proximity Read ↗

Beyond MOG and AQP4 Antibodies: Alternative Causes of Optic NeuritisSemantic proximity Read ↗

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.Semantic proximity Read ↗

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotypeSemantic proximity Read ↗

Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.Semantic proximity Read ↗

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.Semantic proximity Read ↗

Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).Semantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein–Associated DisordersSemantic proximity Read ↗

Unmet Needs in the Care of Patients with Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease: Insights from GermanySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.